Cypherpunk Technologies Inc Dossier
Qualitative Analysis
Business overview
Cypherpunk Technologies Inc. (formerly Leap Therapeutics, Inc.) is a unique publicly traded company that operates under a dual-focus business model. Following a major corporate restructuring and name change in late 2025, the company established a digital asset treasury strategy primarily focused on accumulating Zcash (ZEC), a privacy-preserving cryptographic digital asset. Alongside its digital asset treasury, the company continues to advance its clinical-stage biotechnology operations through its wholly owned subsidiary, Leap Therapeutics, Inc., which is developing targeted immuno-oncology therapies such as sirexatamab (DKN-01) and FL-501.
Research as of 19 Jun 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
Following a $58.88 million private placement led by Winklevoss Capital in October 2025, the company rebranded from Leap Therapeutics to Cypherpunk Technologies to implement a digital asset treasury strategy anchored by Zcash (ZEC). The company actively acquires and holds ZEC as its primary digital asset.
Expected impact: Aims to build long-term shareholder value by accumulating at least 5% of the total circulating supply of the Zcash network.
Conducting ongoing biotechnology research and development operations under its wholly-owned subsidiary, Leap Therapeutics, Inc. The primary focus is developing novel biomarker-targeted antibody therapies, specifically sirexatamab (DKN-01) for colorectal cancer and FL-501 for cachexia-related indications.
Expected impact: Advancing clinical candidates toward potential commercialization or strategic collaborations.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Strategic Partnerships
In March 2026, Cypherpunk made a $5.0 million strategic investment in ZODL, the development team behind the leading Zcash wallet (Zodl). This represents Cypherpunk's first technology investment outside of direct ZEC accumulation, aiming to support Zcash protocol development and wallet adoption.
Terms: $5.0 million cash investment as part of a larger $25 million financing round alongside a16z, Winklevoss Capital, Coinbase, Paradigm, and others.
In December 2025, Zooko Wilcox, the founder of Zcash and former CEO of the Electric Coin Company, joined Cypherpunk Technologies as a Strategic Advisor to guide the company's Zcash-focused treasury and development strategy.
Terms: Not disclosed